Skip to content
Screener

10x Genomics, Inc. TXG Total Operating Expenses

Total Operating Expenses at other companies

TEC
Bio-TechneTECH
$132.79M-24.5%
Bruker logo
BrukerBRKR
$481.3M+39.1%
Illumina logo
IlluminaILMN
$525M+9.1%
Quanterix Corporation logo
Quanterix CorporationQTRX
$56.93M+38.2%
Azenta logo
AzentaAZTA
$76.53M+12.1%
Cytek Biosciences, Inc. logo
Cytek Biosciences, Inc.CTKB
$39.74M+15.2%

Other financials

Income statement

See full
Revenue$151.0M-12.6%
Gross profit$112.5M-10.1%
Operating income-$19.6M-165%
Net income-$17.9M-152%
EPS (diluted)-$0.14-150%

Balance sheet

See full
Cash & equivalents$502.5M+26.4%
Total debt$78.8M-9.2%
Total equity$825.5M+6.8%
Total assets$1.0B+5.1%

Cash flow

See full
Operating cash flow$17.0M-4.1%
CapEx$1.6M+0.6%
Free cash flow$15.4M-4.6%

Valuation

See full
Market cap$5.79B+271%
Enterprise value$5.37B+330%
P/S9.4×+7.0×

Profitability

See full
Gross margin70%+0.5pp
Operating margin-14.3%-1.1pp
Net margin-12.2%-0.8pp
FCF margin19.7%+10.9pp

Returns & leverage

See full
Return on equity-9.4%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.7×-0.1×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054491
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Research and development56,79161,224113,638125,469
Selling, general and administrative78,66174,434145,038164,162
Gain on settlement(3,400)(40,700)(3,400)(49,900)
Total operating expenses132,05294,958255,276239,731
Income (loss) from operations(19,555)30,126(36,601)(9,202)
Other income (expense):
Interest income4,7974,2719,8117,957
Interest expense—(3)—(3)

Item 1. Financial Statements (Unaudited)

FAQ

What is 10x Genomics, Inc.'s total operating expenses?
10x Genomics, Inc. (TXG) reported total operating expenses of $132.05M in Q2 2026.
How has 10x Genomics, Inc.'s total operating expenses changed year-over-year?
10x Genomics, Inc.'s total operating expenses increased by 39.1% year-over-year, from $94.96M to $132.05M.
What is the long-term trend for 10x Genomics, Inc.'s total operating expenses?
Over 4 years (2021 to 2025), 10x Genomics, Inc.'s total operating expenses has grown at a 1.9% compound annual growth rate (CAGR), from $468.65M to $504.87M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Ask your AI about 10x Genomics, Inc.'s total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude